Then, we analyzed the relapse-free survival rate (RFS) of abnormal expression of ATP6AP1, PSMD14 and HSP90AB1 in these 63 HCC tissues and paired non-tumor tissues through five years of follow-up and in the K-M plotter database. This evidence concerns the gene ATP6AP1 and hepatocellular carcinoma.